More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds
Main Author: | Maria Vergoulidou |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-10-01
|
Series: | Biomarker Insights |
Online Access: | http://www.la-press.com/more-than-a-decade-of-tyrosine-kinase-inhibitors-in-the-treatment-of-s-article-a5117 |
Similar Items
-
More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds
by: Maria Vergoulidou
Published: (2015-01-01) -
Two decades with omalizumab: what we still have to learn
by: Incorvaia C, et al.
Published: (2018-10-01) -
What happens when we have no more crude oil?
by: Adenfelt, Elin
Published: (2004) -
Two Decades of TB Drug Discovery Efforts—What Have We Learned?
by: Balachandra Bandodkar, et al.
Published: (2020-08-01) -
What Can We Learn from “Not Much More than g”?
by: Kevin Murphy
Published: (2017-02-01)